The significant predictors of BCSS and DFS were tumor stromal VEGF-A and HER2 and tumor stromal VEGF, respectively, with tumor stromal VEGF-A being the strongest predictor of poor BCSS (HR, 5.0; 95% CI: 2.0-12.3; P <0.01) and DFS (HR, 4.2; 95% CI: 1.7-10.3; P <0.01). The gene discussed is VEGFA; the disease is neoplasm.